MediWound Ltd. (MDWD)
NASDAQ: MDWD · Real-Time Price · USD
17.20
-0.21 (-1.21%)
At close: Mar 3, 2026, 4:00 PM EST
17.20
0.00 (0.00%)
After-hours: Mar 3, 2026, 4:53 PM EST
MediWound Market Cap
MediWound has a market cap or net worth of $220.42 million as of March 3, 2026. Its market cap has increased by 9.71% in one year.
Market Cap
220.42M
Enterprise Value
172.42M
1-Year Change
9.71%
Ranking
Category
Stock Price
$17.20
Market Cap Chart
Since March 20, 2014, MediWound's market cap has decreased from $262.70M to $220.42M, a decrease of -16.09%. That is a compound annual growth rate of -1.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 2, 2026 | 223.11M | -5.73% |
| Dec 31, 2025 | 236.68M | 23.23% |
| Dec 31, 2024 | 192.06M | 104.85% |
| Dec 29, 2023 | 93.76M | 19.44% |
| Dec 30, 2022 | 78.50M | 22.08% |
| Dec 31, 2021 | 64.30M | -36.14% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Surrozen | 226.07M |
| Voyager Therapeutics | 224.07M |
| Heron Therapeutics | 222.47M |
| Prelude Therapeutics | 221.65M |
| Arcturus Therapeutics Holdings | 221.06M |
| Elicio Therapeutics | 221.06M |
| Crescent Biopharma | 218.37M |
| Context Therapeutics | 217.75M |